A dual-gated engineered bacterial platform for spatiotemporally controlled precise protein degradation
Journal of Controlled Release · 2026-12 · 400 · 115459
DOI: 10.1016/j.jconrel.2026.115459 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2026-12. Verfasst von Shangwu Sun und 12 weiteren Autor:innen. Beteiligte Einrichtung: Meizhou Academy of Medical Sciences, Meizhou People's Hospital (Huangtang Hospital), Meizhou, Guangdong, 514031, PR China; Department of Pharmaceutic…. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen Science and Technology Innovation Committee, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Lysosome-targeting chimeras (LYTACs) have attracted much attention due to their ability to specifically target and degrade disease-related proteins on the cell membrane. However, their clinical application is limited by poor tumor specificity, systemic off-target effects, and a lack of temporal regulation. Engineered bacteria naturally home to tumors and serve as in situ production factories, but current approaches typically lack orthogonal regulation over payload release and functional activation, leading to premature exposure and suboptimal efficacy. Here, we develop a dual-gated engineered bacterial platform (DGTPB) that decouples LYTAC delivery from functional activation. Upon tumor colonization, DGTPB constitutively produces genetically encoded LYTACs, triggers their release via L-arabinose-induced bacterial lysis, and subsequently activates targeted degradation through red-light irradiation. This dual-gating design ensures high local LYTAC concentrations while minimizing systemic exposure. We demonstrate that DGTPB-mediated degradation of EGFR and PD-L1 potently suppresses tumor growth and metastasis in both melanoma and breast cancer models. Owing to its modular architecture, DGTPB is readily reprogrammable against diverse disease-associated membrane proteins by simply exchanging targeting ligands. Collectively, DGTPB establishes a versatile, programmable, and safe framework for precision extracellular targeted protein degradation, thereby providing a new tool for engineered-bacteria-based platforms in cancer immunotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Meizhou Academy of Medical Sciences, Meizhou People's Hospital (Huangtang Hospital), Meizhou, Guangdong, 514031, PR China; Department of Pharmaceutical Science, Division of Biomedical Health Sciences, School of Medicine…
- Department of Pharmaceutical Science, Division of Biomedical Health Sciences, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, 518172, PR China; Department of Biomedical Sciences, Division o…
- Meizhou Academy of Medical Sciences, Meizhou People's Hospital (Huangtang Hospital), Meizhou, Guangdong, 514031, PR China.
- Toronto General Hospital Research Institute (TGHRI), University Health Network, Toronto, ONM5G 1L7, Canada; Division of Cardiac Surgery, University Health Network, University of Toronto, Toronto, ON, M5G IL7, Canada.
- Meizhou Academy of Medical Sciences, Meizhou People's Hospital (Huangtang Hospital), Meizhou, Guangdong, 514031, PR China. Electronic address: wuzg1913@163.com.
Förderung
- National Natural Science Foundation of China
- Shenzhen Science and Technology Innovation Committee
- Guangdong Basic and Applied Basic Research Foundation
- China Postdoctoral Science Foundation
Zitieren
APA
Sun, S., Hu, R., Zhai, X., Bai, R., Guo, J., Zhou, T., Yang, T., Zeng, Q., Zhang, Y., Yu, J., Li, R., Wu, Z., & Li, Z. (2026). A dual-gated engineered bacterial platform for spatiotemporally controlled precise protein degradation. Journal of Controlled Release, 400, 115459. https://doi.org/10.1016/j.jconrel.2026.115459
Vancouver
Sun S, Hu R, Zhai X, Bai R, Guo J, Zhou T, et al. A dual-gated engineered bacterial platform for spatiotemporally controlled precise protein degradation. Journal of Controlled Release. 2026;400:115459. doi:10.1016/j.jconrel.2026.115459
BibTeX
@article{Sun2026,
author = {Sun, Shangwu and Hu, Ruoxi and Zhai, Xue and Bai, Rui and Guo, Jiaming and Zhou, Tuoyu and Yang, Tongfu and Zeng, Qinglan and Zhang, Yilin and Yu, Jie and Li, Renke and Wu, Zuguang and Li, Zhaoting},
title = {A dual-gated engineered bacterial platform for spatiotemporally controlled precise protein degradation},
journal = {Journal of Controlled Release},
year = {2026},
volume = {400},
pages = {115459},
doi = {10.1016/j.jconrel.2026.115459}
}
EUVIMED